Percutaneous coronary intervention for left main coronary disease in New Zealand: National linkage study of characteristics and in-hospital outcomes (ANZACS-QI 38)
Cardiovascular revascularization medicine : including molecular interventions | 5 Sep 2019
TKM Wang, A Kerr, C Kasargod, D Chan, S Cicovic, E Dimalapang, M Webster and J Somaratne
Approximately 5% of coronary angiographies detect LMS disease >50%. Recent randomized trials showed PCI has comparable outcomes to coronary artery bypass grafting (CABG) in low or intermediate risk candidates. In clinical practice, PCI is frequently utilized in those with prohibitive surgical risk. We reviewed contemporary national results of percutaneous coronary intervention (PCI) for left main coronary disease (LMS) disease in New Zealand.
* Data courtesy of Altmetric.com